It's been a mediocre week for Inari Amertron Berhad (KLSE:INARI) shareholders, with the stock dropping 14% to RM3.04 in the week since its latest full-year results. It was not a great result overall.

Inari Medical's strategic focus on regulatory approvals and market penetration, particularly in high-growth international markets, has also been noted as a key recent development. Financially, Inari ...

Corteva is suing seed startup Inari for intellectual property theft, alleging in a lawsuit filed in federal court Wednesday that Inari tweaked biotech traits in Corteva’s seeds and is now trying to ...

A Boston-based biotech company with large operations in Indiana has closed on a $103 million funding raise, bringing its cumulative fundraising to more than a half-billion dollars for the ...

Funding will help Inari enhance its “toolbox” of seed technologies to reduce the world’s agricultural footprint and increase crop and food production for people around the world. “There are several ...

Inari Medical is a medical device company that is developing minimally invasive treatments for venous diseases. The company's products include catheters and retrieval devices that are used to remove ...

Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

The analysts might have been a bit too bullish on Inari Amertron Berhad (KLSE:INARI), given that the company fell short of expectations when it released its full-year results last week. Inari Amertron ...